Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Overcoming Trial Exclusion: A Multicenter Analysis of Hemodialysis Multiple Myeloma Patients Who Underwent BCMA-Directed CAR-T Therapy.
Journal: Current oncology (Toronto, Ont.)
Published: June 27, 2026
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma.
Journal: Expert opinion on investigational drugs
Published: April 23, 2026
Persistent cytopenias after anti-BCMA CAR T-cell therapy are associated with reduced hematopoietic activity in posttreatment bone marrows.
Journal: American journal of clinical pathology
Published: April 08, 2024
No needles needed: All-oral therapy options for relapsed and refractory multiple myeloma.
Journal: Blood reviews
Published: May 12, 2022
Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis.
Journal: The Lancet. Haematology
Published: February 10, 2022
Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review.
Journal: Expert review of hematology
Published: August 01, 2020
Strict sequestration versus lenient isolation precautions during hematopoietic stem cell transplant: results of a quality initiative.
Journal: Infection control and hospital epidemiology
Published: September 08, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026